1.
Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals
by Bar-On, Yotam
Nature medicine, 2018, Vol.24 (11), p.1701-1707
2.
A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial
by Kharfan-Dabaja, Mohamed A, MD
The Lancet infectious diseases, 2012, Vol.12 (4), p.290-299
3.
4.
CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia
by van Montfrans, Joris M., MD, PhD
Journal of allergy and clinical immunology, 2011, Vol.129 (3), p.787-793.e6
5.
Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial
by Griffiths, Paul D, Prof
The Lancet (British edition), 2011, Vol.377 (9773), p.1256-1263
6.
Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two m...
by Eron, Joseph J, Prof
The Lancet (British edition), 2010, Vol.375 (9712), p.396-407
7.
Zika viral dynamics and shedding in rhesus and cynomolgus macaques
by Osuna, Christa E
Nature medicine, 2016, Vol.22 (12), p.1448-1455
8.
Antibody 10-1074 suppresses viremia in HIV-1-infected individuals
by Caskey, Marina
Nature medicine, 2017, Vol.23 (2), p.185-191
9.
10.
DNA vaccine protects ornamental koi ( Cyprinus carpio koi ) against North American spring viremia of carp virus
by Emmenegger, E.J
Vaccine, 2008, Vol.26 (50), p.6415-6421
11.
Distinct mechanisms of long-term virologic control in two HIV-infected individuals after treatment interruption of anti-retroviral therapy
by Blazkova, Jana
Nature medicine, 2021, Vol.27 (11), p.1893-1898
12.
Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men
by Thomson, Emma C
Gut, 2011, Vol.60 (6), p.837-845
13.
Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques
by Haigwood, Nancy L
Nature medicine, 2010, Vol.16 (10), p.1117-1119
14.
HIV DNA loads, plasma residual viraemia and risk of virological rebound in heavily treated, virologically suppressed HIV-infected patients
by Gianotti, N
Clinical microbiology and infection, 2015, Vol.21 (1), p.103.e7-103.e10
15.
Adenovirus infection and disease in paediatric haematopoietic stem cell transplant patients: clues for antiviral pre-emptive treatment
by Feghoul, L
Clinical microbiology and infection, 2015, Vol.21 (7), p.701-709
16.
ISG15 expression correlates with HIV-1 viral load and with factors regulating T cell response
by Scagnolari, Carolina
Immunobiology (1979), 2015, Vol.221 (2), p.282-290
17.
Temporal dynamics in viral shedding and transmissibility of COVID-19
by He, Xi
Nature medicine, 2020, Vol.26 (5), p.672-675
18.
A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees
by Nicosia, Alfredo
Nature medicine, 2006, Vol.12 (2), p.190-197
19.
CD8 + T-cell responses to different HIV proteins have discordant associations with viral load
by Goulder, Philip
Nature medicine, 2007, Vol.13 (1), p.46-53
20.
Comparison of epidemiology and clinical characteristics of infections by human parechovirus vs. those by enterovirus during the first month of life
by Cabrerizo, María
European journal of pediatrics, 2015, Vol.174 (11), p.1511-1516
